Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

553.66
Delayed Data
As of Jul 31
 +6.56 / +1.20%
Today’s Change
310.69
Today|||52-Week Range
569.91
+34.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash483.6M230.3M535.6M648.7M
 
 
 
 
 
Short Term Investment Cash371.0M-253.3M305.3M113.1M
 
 
 
 
 
Cash & Short Term Investments526.9M308.1M694.0M900.5M
 
 
 
 
 
 
ReceivablesReceivables103.0M693.1M891.8M1.0B
 
 
 
 
 
 
InventoriesInventories3.5M28.6M70.4M128.9M
 
 
 
 
 
 
Current AssetsOther Current Assets19.4M176.2M140.8M120.7M
 
 
 
 
 
Current Assets652.9M1.2B1.8B2.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross526.1M560.5M748.6M1.2B
 
 
 
 
 
Depreciation-158.1M-180.5M-221.6M-254.0M
 
 
 
 
 
Other Assets19.1M23.1M5.3M3.0M
 
 
 
 
 
Total Assets1.3B2.1B3.0B3.9B
 
 
 
 
 
 
LiabilitiesAccounts Payable27.7M38.9M61.9M99.5M
 
 
 
 
 
Short Term Debt1.0M1.4M939.0K--
 
 
 
 
Accrued Expenses25.1M52.4M119.5M291.9M
 
 
 
 
 
Other Current Liabilities76.7M103.3M166.5M462.4M
 
 
 
 
 
Other Liabilities148.3M163.6M298.8M654.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt437.0M457.3M504.6M457.7M
 
 
 
 
 
Deferred Taxes0.00-192.0M-231.9M-266.9M
 
 
 
 
Other Liabilities3.9M6.0M11.3M40.9M
 
 
 
 
 
Total Liabilities837.9M835.1M998.9M1.3B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity485.7M1.2B2.0B2.5B
 
 
 
 
 
Total Shareholder Equity485.7M1.2B2.0B2.5B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding92.8M97.3M99.7M102.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.